Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trial
fda
loxo oncology
study
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
antidepressant
approval
apremilast
What
cancer
3
×
new
3
×
genetic
medicine
allogene
approved
bio
centers
crispr
cut
deeper
depression
diversity
dna
drug
event
fda
fingerprint
going
guesswork
guide
helps
hot
immunotherapy
investors
ipo
juno
major
making
matter
medical
million
nd
nearly
oks
practice
precise
prescriptions
remains
roundup
Language
Current search:
new
×
cancer
×
" boston blog main "
×
" detroit top stories "
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?